Company Summary:

Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.

Position Summary:

The Scientist, Genetic Epidemiologist will have a critical role in the company’s effort to leverage human genetics to identify therapeutic targets and potential applications in multiple therapeutic areas including Rare Diseases and Oncology.  The successful candidate will be responsible for leveraging publicly available human genetics databases and published literature, in addition to staying abreast of the broader human genetics field to inform therapeutic opportunities and considerations.   

We are searching for a driven, enthusiastic and self-motivated individual who is comfortable multitasking and working independently on various projects. This individual will join a dynamic, rapidly growing, and highly collaborative team.

Key Responsibilities:

  • Survey the literature and attend relevant conferences to incorporate latest findings from the broader human genetics field into internal opportunities and considerations
  • Assess and catalog the mutation spectrum and frequency for indications of interest
  • Analyze publicly available human genetic databases to identify therapeutic targets for Gene Writer and Rewriter platforms
  • Collaborate with internal stakeholders to assess new therapeutic targets, providing genetic epidemiology perspective on potential new projects across multiple therapeutic areas (including Rare Disease and Oncology)
  • Keep abreast of and use of sequencing (whole exome, whole genome, targeted) in diagnostics field and its potential impact on Tessera platforms and therapeutic projects
  • Actively identify and engage potential external collaborators in the human genetics field

Basic Qualifications:

  • PhD in genetic epidemiology, statistical genetics, or related field with strong background in human genetic disease and/or population genetics. Experience in cancer genetics preferred.
  • Hands-on experience in the analysis and interpretation of large human genetic datasets, ideally both GWAS and whole exome/genome sequencing studies
  • Strong interpersonal, strong attention to detail, and excellent communication skills; ability to develop strong relationships with cross-functional team members
  • Ability to adapt to modification and changes in project plans, with demonstrated flexibility to implement new tactics to accommodate changes

 

More About Flagship Pioneering

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has, through its Flagship Labs unit, applied its unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $50B in aggregate value. To date, Flagship has deployed over $2.2B in capital toward the founding and growth of its pioneering companies alongside more than $18B of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics (NASDAQ: FHTX), Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Sigilon Therapeutics (NASDAQ: SGTX).

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Recruitment & Staffing Agencies:  Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates.  The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team.   Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.

Apply for this Job

* Required
  
  
+ Add Another Employment